sec filing
LR
NASDAQ · LRMR
Larimar Therapeutics, Inc.
Healthcare · Biotechnology
$4.27
Up+$0.09 (+2.11%)
Updated Aug 14, 2026, 9:03 PM
SID Score
5.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 343.65M
- P/E ratio
- -2.58
- Dividend yield
- 0.00%
- 52-week range
- $2.92 – $6.00
- Volume
- 1.5M
- Avg. volume
- 2.64M
Price performance
LRMR price history
1M range · 21 trading sessions · Daily adjusted prices
LRMR closed at $4.27 after 21 trading sessions, up 16.35% for the selected period.
- Last close
- $4.27
- Period change
- +16.35%
- Period low
- $3.63
- Period high
- $4.37
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2026 | $4.38 | $4.465 | $4.23 | $4.27 | 1.5M |
| Aug 12, 2026 | $4.31 | $4.40 | $4.275 | $4.37 | 1.18M |
| Aug 11, 2026 | $4.04 | $4.385 | $4.02 | $4.31 | 1.66M |
| Aug 10, 2026 | $4.15 | $4.29 | $4.005 | $4.01 | 1.4M |
| Aug 7, 2026 | $4.24 | $4.28 | $4.08 | $4.16 | 631.19K |
| Aug 6, 2026 | $4.19 | $4.31 | $4.14 | $4.20 | 759.75K |
| Aug 5, 2026 | $4.11 | $4.29 | $4.075 | $4.10 | 1.28M |
| Aug 4, 2026 | $3.98 | $4.1388 | $3.82 | $4.11 | 1.68M |
| Aug 3, 2026 | $3.83 | $4.00 | $3.74 | $3.98 | 793.83K |
| Jul 31, 2026 | $3.82 | $3.86 | $3.715 | $3.82 | 1.06M |
| Jul 30, 2026 | $3.65 | $3.895 | $3.60 | $3.825 | 1.03M |
| Jul 29, 2026 | $3.81 | $3.895 | $3.615 | $3.63 | 1.8M |
| Jul 28, 2026 | $3.84 | $3.86 | $3.68 | $3.83 | 1.78M |
| Jul 27, 2026 | $4.00 | $4.06 | $3.805 | $3.83 | 1.74M |
| Jul 24, 2026 | $4.03 | $4.16 | $3.975 | $4.00 | 1.23M |
| Jul 23, 2026 | $4.01 | $4.10 | $3.9301 | $4.01 | 698.87K |
| Jul 22, 2026 | $3.90 | $4.17 | $3.90 | $4.02 | 1.31M |
| Jul 21, 2026 | $3.83 | $3.985 | $3.74 | $3.93 | 970.09K |
| Jul 20, 2026 | $3.76 | $3.895 | $3.73 | $3.83 | 1.4M |
| Jul 17, 2026 | $3.61 | $3.785 | $3.605 | $3.70 | 1.39M |
| Jul 16, 2026 | $3.80 | $3.80 | $3.535 | $3.67 | 1.34M |
Latest LRMR news
The latest Smart Investors Daily articles mentioning LRMR.
Stock researchCompany · Financials
Loading stock research…